DEBT CONVERSION AGREEMENTDebt Conversion Agreement • January 3rd, 2025 • Neonc Technologies Holdings, Inc. • Pharmaceutical preparations
Contract Type FiledJanuary 3rd, 2025 Company IndustryTHIS DEBT CONVERSION AGREEMENT (the “Agreement”) is entered into as of June 6, 2024, by and between NeOnc Technologies Holdings, Inc., a Delaware corporation (the “Company”),and Thomas C. Chen, MD, a current officer and director of the Company (the “Lender”). The Company and Lender may be referred to herein individually as a “Party” and collectively as the “Parties.”
DEBT CONVERSION AGREEMENTDebt Conversion Agreement • January 3rd, 2025 • Neonc Technologies Holdings, Inc. • Pharmaceutical preparations
Contract Type FiledJanuary 3rd, 2025 Company IndustryTHIS DEBT CONVERSION AGREEMENT (the “Agreement”) is entered into as of June 6, 2024, by and between NeOnc Technologies Holdings, Inc., a Delaware corporation (the “Company”),and Patrick Walters, a current officer of the Company (the “Lender”). The Company and Lender may be referred to herein individually as a “Party” and collectively as the “Parties.”